Skip to main content

09-08-2018 | Gout | Article

Can we predict inadequate response to allopurinol dose escalation? Analysis of a randomized controlled trial

Stamp LK et al. Rheumatology (Oxford) 2018: key237. doi: 10.1093/rheumatology/key237

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

Related topics

EULAR 2020 E-Congress hub

Access the latest news and expert video commentary from the EULAR 2020 E-Congress.

Image Credits